Drug combo tested to shrink tumors before liver surgery
NCT ID NCT03844750
Summary
This study tested if giving two drugs—pembrolizumab and vactosertib—after standard chemotherapy but before surgery could help shrink colorectal cancer that had spread to the liver. The goal was to make surgery more effective and lower the chance of the cancer coming back. After surgery, some participants could optionally continue the drugs for up to a year. The trial was terminated early after enrolling only 6 people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV COLORECTAL CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.